Can This Small Biotech Enter A $4.3 Billion AbbVie Market? Rapport Shoots Higher

Rapport Therapeutics stock shot higher Tuesday on promising, but mixed, test results for its bipolar treatment. The post Can This Small Biotech Enter A $4.3 Billion AbbVie Market? Rapport Shoots Higher appeared first on Investor's Business Daily.